CURR CURE Pharmaceutical Holding Corp.

CURE Pharmaceutical Holding Corp. is a biopharmaceutical company. The firm focuses on development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms to improve drug safety and patient adherence. Its commercial products include CURE 3068, and CURE 5079. The company was founded on May 15, 2014 and is headquartered in Oxnard, CA.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.30    OTCQB
As of 01/27/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Discretionary
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  
IPO date:  01/19/2017
Outstanding shares:  74,131,966
Average volume:  124,344
Market cap:   $21,868,930
Current dividend yield:  0.00%
Valuation   (See tab for details)
PE ratio:   -0.86
PB ratio:   1.03
PS ratio:   3.52
Return on equity:   -136.20%
Net income %:   -407.34%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy